Sign in or register to see full information and data.

Studies / CAVD 361

Overview

Study information

Network:CAVD
Grant Affiliation:Third party request
Strategy:Combo: DNA & protein vaccines
Study Type:Pre-Clinical Non-NHP
Species:Rabbit
Stage:Assays Completed
Study Start Date:2012-04-04
Study Made Public:2012-08-14

Title

Rabbit Immunogenicity Study with a Clade A gp120 Env protein expressing the PG9 epitope in A3R5 assay (C0692-11)

Description

CAVD 361 (CAVIMC-041, C0692-11) is a preclinical rabbit study to compare the immunogenicity and induction of neutralizing antibodies to gp120 Env proteins discordant for binding to the PG9 broadly neutralizing antibody.